Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Björn Timmerbeil has worked on the following 10 EPO patent applications which have been published in the last five years:

EP13151034

Oxazolopyrimidines as Edg-1 receptor agonists

IPC classification:
A61K 31/519, A61P 9/10, C07D 498/04, C07D 519/00
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP14163127

Pharmaceutical composition for treating a metabolic syndrome

IPC classification:
A61K 38/18, A61K 38/26, A61P 3/00
Applicant:
Sanofi, S.A.
Agent:
Thomas Böhmer, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Björn Timmerbeil, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP11305939

Pharmaceutical composition for treating a metabolic syndrome

IPC classification:
A61K 31/155, A61K 38/18, A61K 38/26, A61P 3/10
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13758851

FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME

IPC classification:
A61K 38/18, A61K 38/26, C07K 14/50, C07K 14/605
Applicant:
Sanofi, S.A.
Agent:
Thomas Böhmer, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Björn Timmerbeil, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION IN PROGRESS
EP11700669

Pharmaceutical composition for treating a metabolic syndrome

IPC classification:
A61K 38/18, A61K 38/26, A61P 3/00
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14702567

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES

IPC classification:
A61K 9/00, A61K 9/02, A61K 38/28, A61K 47/18, A61P 3/10
Applicant:
Sanofi, S.A.
Agent:
Jörk Zwicker, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Björn Timmerbeil, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION IN PROGRESS
EP11726768

HETEROCYCLIC SUBSTITUTED METHOXYPHENYL DERIVATIVES WITH OXOGROUP, METHOD FOR PRODUCING SAME AND USE AS GPR40 RECEPTOR MODULATORS

IPC classification:
A61K 31/404, A61K 31/428, A61K 31/4704, A61K 31/538, A61K 31/5383, C07D 209/34, C07D 215/227, C07D 265/36, C07D 277/68, C07D 498/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15700071

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ASPART

IPC classification:
A61K 9/00, A61K 9/08, A61K 38/28, A61K 47/02, A61K 47/10, A61P 3/10
Applicant:
Sanofi, S.A.
Agent:
Jörk Zwicker, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Björn Timmerbeil, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION REQUESTED
EP15700106

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES

IPC classification:
A61K 9/00, A61K 9/08, A61K 38/28, A61K 47/02, A61K 47/10, A61K 47/26, A61P 3/10
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Jörk Zwicker, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Björn Timmerbeil, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION REQUESTED
EP15700966

STABILIZED GLYCEROL FREE PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES

IPC classification:
A61K 9/00, A61K 9/08, A61K 38/28, A61K 47/02, A61K 47/10, A61P 3/10
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Jörk Zwicker, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Björn Timmerbeil, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature